Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/124278
Actinic Keratosis, a Chronic, Progressive Disease: Understanding Clinical Gaps to Optimise Patient Management
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
Actinic keratosis (AK) is a chronic, progressive disease
of the skin that has undergone long-term sun exposure.
The affected areas contain visible and subclinical nonvisible
sun damage resulting in epidermal keratinocyte
dysplasia, known by many as ‘field cancerisation’ (1),
which is prone to AKs and sun-related skin cancer (2).
Thus, visible AKs are clinical biomarkers for a photo-damaged
field with subclinical damage associated with the
unpredictable risk of progression to invasive squamous
cell carcinoma (iSCC) (3). The aim of this multiexpert
opinion article is to provide a discussion succinctly
highlighting the clinical gaps for optimal management of
AK: the lack of a universal definition and the need for a
standardised grade assessment of AK/field cancerisation
that also takes into account individual risk.
Subject
Subject (English)
Citation
Citation
CERIO, Rino, et al. Actinic Keratosis, a Chronic, Progressive Disease: Understanding Clinical Gaps to Optimise Patient Management. Acta Dermato-Venereologica. 2017. Vol. 97, num. 8, pags. 997-998. [consulted: 14 of August of 2026]. Available at: https://hdl.handle.net/2445/124278